PACAP: Lessons From A Potent Migraine Inducer?
May 11, 2015
PACAP38 is a potent aggravator of migraine, a new study shows. This provides several new potential therapeutic targets -- most prominently a specific PACAP receptor PAC1.
Thomas P. Bravo, MD
An Imaging Biomarker for Migraine?
May 5, 2015
Intriguing research is helping to shape our understanding of the functional connectivity and brain structure of migraineurs.
New Insights on Post-Traumatic Headache
April 23, 2015
Highlights of the first large study to describe the characteristics of post-traumatic headache and treatment response in children are summarized here.
A Novel Acute Migraine Treatment
April 23, 2015
A novel drug-device may not only be a promising non-oral triptan acute migraine treatment, but may be more efficacious than its oral counterpart.
Sphenopalatine Ganglion Block for Migraine?
April 7, 2015
The SPG is a promising target for migraine treatment, but robust evidence of efficacy for routine use of noninvasive device–mediated SPG blockade is needed.
Poor Acute Treatment May Lead to Chronic Migraine
March 4, 2015
Efficacy of acute medication matters beyond just treating a single migraine. It may increase the risk of worsened disease.
Migraine Preventative Butterbur Has Safety Concerns
January 28, 2015
Despite butterbur’s potential efficacy, doubts are increasing about its long-term safety given of the risk of liver damage and the lack of an actively regulated preparation.
sTMS: Promising Migraine Therapy
January 9, 2015
Transcranial magnetic stimulation is a promising, effective, well-tolerated and safe treatment option for migraine with and without aura, episodic or chronic.
Imploding or Exploding: Headache Direction May Help Select Treatment
October 17, 2014
Knowing the direction of the headache's origin, while clinically difficult to ascertain on a consistent basis, has shown some predictive value for migraines.
Migraine Rx in the ED: A Systematic Review
September 2, 2014
Here: highlights from a systematic review that these authors view as a substantial step forward in establishing an evidence-based approach to migraine treatment in the acute care setting.
